SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mary Ann Cloyd” (as Signatory)
for/with Bellerophon Therapeutics, Inc. (as Filer)


        

14  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
10/16/23  Bellerophon Therapeutics, Inc.    S-8 POS    10/16/23    1:30K                                    Toppan Merrill/FA        
  6/7/23  Bellerophon Therapeutics, Inc.    S-8          6/7/23    4:94K                                    Toppan Merrill/FA        
  6/2/23  Bellerophon Therapeutics, Inc.    S-3                    7:1.6M                                   Toppan Merrill/FA        
 3/31/23  Bellerophon Therapeutics, Inc.    10-K       12/31/22   66:7.3M                                   Toppan Merrill Bridge/FA 
 3/31/22  Bellerophon Therapeutics, Inc.    10-K       12/31/21   66:7.5M                                   Toppan Merrill Bridge/FA 
 6/11/21  Bellerophon Therapeutics, Inc.    S-8         6/11/21    3:129K                                                            
 3/11/21  Bellerophon Therapeutics, Inc.    10-K       12/31/20   72:8.8M                                   Toppan Merrill Bridge/FA 
____________
 ¹  Filing/Form Types: 
Type emoji
  10-K    Annual Report — Form 10-K.
  S-3    Registration Statement – Securities for a Transaction — Form S-3.
  S-8    Registration Statement – Securities for an Employee Benefit Plan — Form S-8.
  S-8 POS    Post-Effective Amendment of a Form S-8 Registration.

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 3:55:57.3pm ET